Nanoparticles enable targeted mRNA delivery to the pancreas

Researchers at UNLV have developed a novel nanoparticle system called ENDO that can selectively deliver mRNA directly to the pancreas by leveraging the body's Vitamin D receptors, potentially revolutionizing treatments for pancreatic diseases like diabetes and cancer with increased precision and fewer side effects.